London, United Kingdom, Tuesday 26th 2026: King’s College London has spun out Korecyte Bio Ltd (Korecyte) and Cell and Gene Therapy Catapult (CGT Catapult) has enabled the spinout, through transactional expertise and investment, to accelerate the therapeutic development and clinical readiness of its lead candidate in solid cancers.